|
Diabetes, Vol 49, Issue 7 1258-1263, Copyright © 2000 by American Diabetes Association
Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration
F Chiarelli, F Cipollone, F Romano, S Tumini, F Costantini, L di Ricco, M Pomilio, SD Pierdomenico, M Marini, F Cuccurullo and A Mezzetti
Centro per lo Studio dell'Ipertensione Arteriosa delle Dislipidemie e dell'Aterosclerosi, Department of Biomedical Sciences, University G.D'Annunzio School of Medicine, Chieti, Italy.
Hyperglycemia has been causally linked to vascular and glomerular
dysfunction by a variety of biochemical mechanisms, including a
glucose-dependent abnormality in nitric oxide (NO) production and action.
NO is a candidate for mediating hyperfiltration and the increased vascular
permeability induced by diabetes. Serum nitrite and nitrate (NO2-+ NO3-)
concentrations were assessed as an index of NO production in 30 adolescents
and young adults with type 1 diabetes, 15 with and 15 without
microalbuminuria (albumin excretion rate [AER] between 20 and 200
microg/min), compared with a well-balanced group of healthy control
subjects. In all subjects, glomerular filtration rate (GFR) was determined
by radionuclide imaging. Our study showed that NO2- + NO3- serum content
and GFR values were significantly higher in microalbuminuric diabetic
patients than in the other 2 groups. GFR was significantly and positively
related to AER levels (r2 = 0.75, P < 0.0001), whereas NO2- + NO3- serum
content was independently associated with both AER and GFR values (beta =
2.086, P = 0.05, beta = 1.273, P = 0.0085, respectively), suggesting a
strong link between circulating NO, glomerular hyperfiltration, and
microalbuminuria in young type 1 diabetic patients with early nephropathy.
Interestingly, mean HbA1c, serum concentration was significantly higher in
microalbuminuric than in normoalbuminuric diabetic subjects (P < 0.05)
and was independently associated with AER values, suggesting a role for
chronic hyperglycemia in the genesis of diabetic nephropathy. Moreover,
HbA1c serum concentration was significantly and positively related to NO2 +
NO3 serum content (r2 = 0.45, P = 0.0063) and GFR values (r2 = 0.57, P =
0.0011), suggesting that chronic hyperglycemia may act through a mechanism
that involves increased NO generation and/or action. In conclusion, we
suggest that in young type 1 diabetic patients with early nephropathy,
chronic hyperglycemia is associated with an increased NO biosynthesis and
action that contributes to generating glomerular hyperfiltration and
persistent microalbuminuria.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Z.I. Cherney, J. A. Miller, J. W. Scholey, T. J. Bradley, C. Slorach, J. R. Curtis, M. G. Dekker, R. Nasrallah, R. L. Hebert, and E. B. Sochett
The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes
Diabetes,
March 1, 2008;
57(3):
688 - 695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Skaleric, B. Gaspirc, N. McCartney-Francis, A. Masera, and S. M. Wahl
Proinflammatory and Antimicrobial Nitric Oxide in Gingival Fluid of Diabetic Patients with Periodontal Disease
Infect. Immun.,
December 1, 2006;
74(12):
7010 - 7013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Savino, P. Pelliccia, C. Schiavone, A. Primavera, S. Tumini, A. Mohn, and F. Chiarelli
Serum and Urinary Nitrites and Nitrates and Doppler Sonography in Children With Diabetes
Diabetes Care,
December 1, 2006;
29(12):
2676 - 2681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Y. Salazar-Vazquez, M. Intaglietta, M. Rodriguez-Moran, and F. Guerrero-Romero
Blood Pressure and Hematocrit in Diabetes and the Role of Endothelial Responses in the Variability of Blood Viscosity
Diabetes Care,
July 1, 2006;
29(7):
1523 - 1528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Sochett, D. Z.I. Cherney, J. R. Curtis, M. G. Dekker, J. W. Scholey, and J. A. Miller
Impact of Renin Angiotensin System Modulation on the Hyperfiltration State in Type 1 Diabetes
J. Am. Soc. Nephrol.,
June 1, 2006;
17(6):
1703 - 1709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Londono and M. Bendayan
Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney
Am J Physiol Renal Physiol,
December 1, 2005;
289(6):
F1201 - F1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Chiarelli, D. Di Marzio, F. Santilli, A. Mohn, A. Blasetti, F. Cipollone, A. Mezzetti, and A. Verrotti
Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy
Diabetes Care,
July 1, 2005;
28(7):
1690 - 1697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pistrosch, K. Herbrig, B. Kindel, J. Passauer, S. Fischer, and P. Gross
Rosiglitazone Improves Glomerular Hyperfiltration, Renal Endothelial Dysfunction, and Microalbuminuria of Incipient Diabetic Nephropathy in Patients
Diabetes,
July 1, 2005;
54(7):
2206 - 2211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg
From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines
Endocr. Rev.,
December 1, 2004;
25(6):
971 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. A. Stehouwer
Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease
Nephrol. Dial. Transplant.,
April 1, 2004;
19(4):
778 - 781.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. De Cobelli, P. Fiorina, G. Perseghin, M. Magnone, M. Venturini, G. Zerbini, A. Zanello, G. Mazzolari, L. Monti, V. Di Carlo, et al.
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Preserved in Uremic Type 1 Diabetic Patients After Kidney and Pancreas but not After Kidney-Alone Transplantation
Diabetes Care,
April 1, 2004;
27(4):
947 - 954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Brands, T. D. Bell, and B. Gibson
Nitric Oxide May Prevent Hypertension Early in Diabetes by Counteracting Renal Actions of Superoxide
Hypertension,
January 1, 2004;
43(1):
57 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Delles, M. P. Schneider, S. Oehmer, E. H. Fleischmann, and R. E. Schmieder
L-Arginine-Induced Vasodilation of the Renal Vasculature Is Not Altered in Hypertensive Patients With Type 2 Diabetes
Diabetes Care,
June 1, 2003;
26(6):
1836 - 1840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Hoeldtke, K. D. Bryner, D. R. McNeill, S. S. Warehime, K. Van Dyke, and G. Hobbs
Oxidative Stress and Insulin Requirements in Patients with Recent-Onset Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1624 - 1628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Hoeldtke, K. D. Bryner, D. R. McNeill, G. R. Hobbs, J. E. Riggs, S. S. Warehime, I. Christie, G. Ganser, and K. Van Dyke
Nitrosative Stress, Uric Acid, and Peripheral Nerve Function in Early Type 1 Diabetes
Diabetes,
September 1, 2002;
51(9):
2817 - 2825.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|